Further studies are required to clarify the signaling axis effects and analyze the protein structure of TET1 targeting SIRT1, providing more precise targets for the clinical therapy to type 2 diabetes or metabolism-related diseases. This evidence concerns the gene SIRT1 and type 2 diabetes mellitus.